James Bradley Breitmeyer

Title: **James Bradley Breitmeyer: Innovator in Cancer Treatment**

Introduction

James Bradley Breitmeyer is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of oncology. With a total of four patents to his name, Breitmeyer is making strides in the treatment of serious ailments like acute myeloid leukemia and diffuse large B-cell lymphoma.

Latest Patents

His latest patents focus on the "Uses of indolinone compounds" and provide methods and compositions for treating acute myeloid leukemia and diffuse large B-cell lymphoma. These patents involve innovative combinations of venetoclax and indolinone derivatives, representing a promising approach to cancer therapy.

Career Highlights

Currently affiliated with Oncternal Therapeutics, Inc., Breitmeyer plays a crucial role in advancing research in cancer therapies. His work is pivotal in exploring new treatment options that could potentially change the lives of many patients suffering from these aggressive cancers.

Collaborations

Breitmeyer has worked alongside talented colleagues, including Brian Lannutti and Katayoun Jessen, fostering an environment of collaboration to drive forward innovative solutions in the medical field.

Conclusion

James Bradley Breitmeyer exemplifies the spirit of innovation in the healthcare sector. His contributions not only enhance the understanding of critical diseases but also pave the way for future advancements in cancer treatment. Through his dedication and expertise, Breitmeyer continues to make a lasting impact on the lives of patients battling cancer.